Cavitation Technologies (CVAT) Stock Price, News & Analysis

Company Overview

Cavitation Technologies Inc (OTCMKTS:CVAT) is a U.S.-based developer of advanced cavitation systems designed to deliver environmental, industrial and medical solutions. Leveraging proprietary ultrasonic and hydrodynamic cavitation processes, the company’s platforms generate microscopic bubbles that collapse with high energy, enabling non-thermal pasteurization, targeted cell disruption and enhanced chemical reactions. Its core offerings include modular reactor units and custom-engineered treatment systems that address challenges such as water purification, oil-water separation, biofilm removal and waste-to-energy conversion.

In the environmental sector, Cavitation Technologies’ equipment is applied to municipal and industrial wastewater facilities for efficient removal of organic contaminants, heavy metals and pathogens. The company also targets mining and oil & gas operations, where its systems can demulsify oil-laden brine, neutralize hydrocarbons and reduce sludge volumes. In parallel, the firm pursues medical and aesthetic markets by exploring the use of focused cavitation for non-invasive therapies, including fat reduction and tissue regeneration, under applicable regulatory pathways.

Established in the late 2000s, Cavitation Technologies has built a portfolio of patents covering reactor design, control algorithms and scale-up methodologies. The company conducts pilot trials and collaborates with academic institutions to validate performance across diverse feedstocks and operating conditions. With manufacturing and service centers in North America and strategic partnerships in Europe and Asia, it supports both turnkey installations and licensing agreements tailored to regional regulatory requirements.

Led by CEO Patrick Bumstead, Cavitation Technologies maintains a leadership team with combined expertise in chemical engineering, process development and commercial deployment. The board comprises industry veterans who have guided the company through early-stage research, product commercialization and expansion into new application areas. As it advances its technology roadmap, Cavitation Technologies continues to strengthen its intellectual property and pursue joint ventures aimed at accelerating market adoption worldwide.

Key Stats

• Today's Range: $0.02 to $0.03
• 50-Day Range: $0.02 to $0.03
• 52-Week Range: $0.00 to $0.04
• Volume: 1.37 million shs
• Average Volume: 384,401 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CVAT Stock Analysis - Frequently Asked Questions

How have CVAT shares performed this year?

Cavitation Technologies' stock was trading at $0.0189 at the start of the year. Since then, CVAT shares have increased by 24.3% and is now trading at $0.0235.

How do I buy shares of Cavitation Technologies?

Shares of CVAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cavitation Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cavitation Technologies investors own include Adamis Pharmaceuticals (ADMP), Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Altimmune (ALT) and Digital Ally Inc./NV (DGLY).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Specialty Industrial Machinery
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:CVAT
• CIK: 1376793
• Web: www.ctinanotech.com
• Phone: (818) 718-0905
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A